Back
Range Cancer Therapeutics ETF Vs. Texas Pacific Land Industry Stock Comparison
Sell
47
CNCR
Range Cancer Therapeutics ETF
Last Price:
13.62
Seasonality Move:
2.55%
Buy
69
TPL
Texas Pacific Land
Last Price:
1,731.72
Seasonality Move:
5.54%
Sell
47
Range Cancer Therapeutics ETF (CNCR)
is a Sell
Is Range Cancer Therapeutics ETF a Buy, Sell or Hold?
- The current Range Cancer Therapeutics ETF [CNCR] share price is $13.56. The Score for CNCR is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
- CNCR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
69
Texas Pacific Land (TPL)
is a Buy
Is Texas Pacific Land a Buy, Sell or Hold?
- The current Texas Pacific Land [TPL] share price is $1,730.00. The Score for TPL is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
- TPL is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CNCR Stock Price Chart
What is Range Cancer Therapeutics ETF's stock price today?
-
The Range Cancer Therapeutics ETF share price today is $13.56
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CNCR is experiencing slight buying pressure.
TPL Stock Price Chart
What is Texas Pacific Land's stock price today?
-
The Texas Pacific Land share price today is $1,730.00
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TPL is experiencing buying pressure, which is a positive indicator for future bullish movement.
CNCR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.43 | Sell |
| Relative Strength Index (14 RSI): | 36.72 | Sell |
| Chaikin Money Flow: | 1180 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (13.87 - 15.47) | Sell |
| Bollinger Bands (100): | (14.08 - 15.46) | Sell |
TPL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 127.94 | Buy |
| Relative Strength Index (14 RSI): | 92.1 | Buy |
| Chaikin Money Flow: | 559044 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1115.8 - 1446.52) | Buy |
| Bollinger Bands (100): | (749.53 - 1176.17) | Buy |
CNCR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 13.68 | Sell |
| 20-day SMA: | 14.6 | Sell |
| 50-day SMA: | 14.86 | Sell |
| 200-day SMA: | 15.05 | Sell |
| 8-day EMA: | 13.76 | Sell |
| 20-day EMA: | 14.32 | Sell |
| 50-day EMA: | 14.66 | Sell |
| 200-day EMA: | 14.55 | Sell |
TPL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1450.33 | Buy |
| 20-day SMA: | 1329.52 | Buy |
| 50-day SMA: | 1115.06 | Buy |
| 200-day SMA: | 778.77 | Buy |
| 8-day EMA: | 1485.56 | Buy |
| 20-day EMA: | 1353.69 | Buy |
| 50-day EMA: | 1170.74 | Buy |
| 200-day EMA: | 861.48 | Buy |
Range Cancer Therapeutics ETF Earnings Growth & CNCR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Texas Pacific Land Earnings Growth & TPL Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.14 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.73 per share, and an increase next year of $2.99 per share.
Range Cancer Therapeutics ETF Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Texas Pacific Land Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||